Tuberculosis Trials in Newark, United States
Conditions / Tuberculosis / Newark, United States
Research into Tuberculosis spans multiple therapeutic approaches and trial phases.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00000955 | Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection | COMPLETED | NA |
| NCT00000785 | A Registry of Tuberculosis Cases in the CPCRA | COMPLETED | — |
| NCT00023361 | TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen | COMPLETED | NA |
| NCT01404312 | Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB) | COMPLETED | PHASE3 |
| NCT00000638 | Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection | COMPLETED | NA |
| NCT00000636 | Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection | COMPLETED | NA |
| NCT00023413 | TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz | COMPLETED | PHASE2 |
| NCT00000959 | Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection | COMPLETED | NA |
| NCT00023348 | TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB | COMPLETED | PHASE2/PHASE3 |
| NCT00023400 | TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB | COMPLETED | PHASE4 |